Unknown

Dataset Information

ISX-9 potentiates CaMKIIδ-mediated BMAL1 activation to enhance circadian amplitude.


ABSTRACT: Circadian dysregulation associates with numerous diseases including metabolic dysfunction, sleep disorder, depression and aging. Given that declined circadian amplitude is a trait commonly found with compromised health, interventions that design in precluding circadian amplitude from dampening will aid to mitigate complex, circadian-related diseases. Here we identify a neurogenic small molecule ISX-9 that is able to support persistent and higher amplitude of circadian oscillations. ISX-9 improves diurnal metabolic rhythms in middle-aged mice. Moreover, the ISX-9-treated mice show better sleep homeostasis with increased delta power during the day time and higher locomotive activity in the dark period. ISX-9 augments CaMKIIδ expression and increases BMAL1 activity via eliciting CaMKIIδ-media

SUBMITTER: Li H 

PROVIDER: S-EPMC9334596 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature